Table 1.
YEATS4 abnormal expression correlates with clinic-pathological factors of HCC patients
| Clinical-pathology Factors | A abnormal expression | N | X2 | P |
|---|---|---|---|---|
| Age (yr) | ||||
| < 55 | 20 (80.0%) | 25 | 0.125 | 0.724 |
| ≥ 55 | 40 (83.3%) | 48 | ||
| Gender | ||||
| Male | 35 (83.3%) | 42 | 0.088 | 0.768 |
| Female | 25 (80.6%) | 31 | ||
| Tumor size | ||||
| < 5 cm | 21 (70.0%) | 30 | 5.172 | 0.023* |
| ≥ 5 cm | 39 (90.7%) | 43 | ||
| Metastasis | ||||
| Yes | 38 (92.7%) | 41 | 7.033 | 0.008** |
| No | 22 (68.8%) | 32 | ||
| Differentiation | ||||
| Poor | 28 (93.3%) | 30 | 5.074 | 0.034* |
| Moderate | 12 (85.7%) | 14 | ||
| Well | 20 (71.4%) | 28 | ||
| Liver cirrhosis status | ||||
| No | 19 (73.1%) | 26 | 2.261 | 0.200 |
| Yes | 41 (87.2%) | 47 | ||
| Serum HBV level (cps/ml) | ||||
| < 1000 | 26 (83.9%) | 31 | 0.166 | 0.684 |
| ≥ 1000 | 28 (80.0%) | 35 | ||
| Serum AFP level (ug/L) | ||||
| < 400 | 27 (79.4%) | 34 | 0.279 | 0.597 |
| ≥ 400 | 32 (84.2%) | 38 |
*
p < 0.05;
**
P < 0.01.